Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.21.2
Commitments and Contingencies (Details Narrative)
9 Months Ended
Nov. 03, 2020
Dec. 13, 2019
USD ($)
$ / shares
shares
Dec. 13, 2019
EUR (€)
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2021
EUR (€)
Sep. 30, 2021
EUR (€)
Dec. 31, 2020
USD ($)
Total Long-Term Debt       $ 2,787,389      
Compensation expenses       219,077      
Stock option expenses       190,981      
Payments for future research and collobration       932,999      
Short term lease costs       58,720      
Aggerate amount payable, description the Company to pay in aggregate of up to $2.9 million over a period of 22 months.            
Operating lease right-of-use assets       263,440     $ 326,085
Managing Director's Agreement [Member]              
Amount payable       229      
Royalty payment       $ 41,677      
Royality       6.00% 6.00%    
Stock based compensation expenses       $ 753,000      
Stock Incentive Plan [Member]              
Restricted stock       460,191      
Total of stock option       $ 926,640      
Founder [Member] | Managing Director's Agreement [Member]              
Fixed interest rate       6.00%   6.00%  
In 2018 [Member] | Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member]              
Amount payable       $ 124,270      
Terms of agreement description       The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €181,500 and the 3.53% royalty on revenue, is equal to the amount of funding received.    
Repayment of grants | €           € 181,500  
Grant receivable | €           605,000  
In 2018 [Member] | University of Taiwan [Member] | Clinical Study Research Agreement [Member]              
Collaborative obligations amount due       $ 510,000      
Lease agreement expire period       3 years 3 years    
Collaborative obligations amount       $ 2,550,000      
In 2018 [Member] | BNP Paribas leasing solutions [Member] | Finance Lease Obligations [Member]              
Amount payable       $ 3,896      
Purchase price for the property | €           € 25,000  
Maturity date       Jan. 31, 2022 Jan. 31, 2022    
Implicit interest       1.35%   1.35%  
Leased equipment amortized term       5 years 5 years    
In 2010 [Member] | Walloon Region Government [Member]              
Amount payable       $ 63,673      
Terms of agreement description       it is due to pay a 6% royalty on such revenue to the Walloon Region. it is due to pay a 6% royalty on such revenue to the Walloon Region.    
Repayment of grants | €           € 314,406  
In 2020 [Member] | Walloon Region Government [Member]              
Amount payable       $ 59,836      
Terms of agreement description       The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €148,500 and the 2.89% royalty on revenue, is equal to the amount of funding received.    
Repayment of grants | €           148,500  
Grant receivable | €           € 495,000  
Fixed interest rate on lease       2.89%   2.89%  
In 2020 [Member] | Walloon Region Government [Member] | Colorectal Cancer Research Agreement [Member]              
Amount payable       $ 53,765      
Terms of agreement description       The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is equal to twice the amount of funding received. The maximum amount payable to the Walloon Region, in respect of the aggregate of the amount repayable of €314,406 and the 6% royalty on revenue, is equal to twice the amount of funding received.    
Repayment of grants | €           € 278,830  
Grant receivable | €           € 929,433  
Fixed interest rate on lease       4.34%   4.34%  
In 2016 [Member] | ING [Member] | Long-term Debt [Member]              
Purchase price for the property | €           € 1,120,000  
Fixed interest rate on lease       2.62%   2.62%  
Lease payable       $ 580,355      
In 2016 [Member] | ING [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Fixed interest rate       2.62%   2.62%  
Repayment of long-term loan amount | €         € 270,000    
Principal balance payable       $ 227,954      
Loan agreement term       15 years 15 years    
In 2016 [Member] | Namur Invest [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Maturity date       December 2031 December 2031    
Fixed interest rate       4.85%   4.85%  
Repayment of long-term loan amount | €         € 440,000    
Loan agreement term       7 years 7 years    
Total long-term debt       $ 194,720      
In 2016 [Member] | DKFZ [Member] | Research Co-operation Agreement [Member]              
Collaborative obligations amount due       $ 231,539      
Lease agreement expire period       5 years 5 years    
Collaborative obligations amount | €           € 400,000  
In 2017 [Member] | Namur Invest [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Maturity date       June 2021 June 2021    
Fixed interest rate       4.00%   4.00%  
Repayment of long-term loan amount | €         € 350,000    
Loan agreement term       4 years 4 years    
Total long-term debt       $ 0      
In 2017 [Member] | SOFINEX [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Maturity date       September 2024 September 2024    
Fixed interest rate       4.50%   4.50%  
Repayment of long-term loan amount | €         € 1,000,000    
Loan agreement term       7 years 7 years    
Total long-term debt       $ 810,388      
In 2019 [Member] | Taxes A&M University [Member]              
Repayment of long-term loan amount       $ 400,000      
Loan agreement term       5 years 5 years    
Collaborative obligations amount due       $ 98,711      
In 2019 [Member] | Namur Invest [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Maturity date       September 2024 September 2024    
Fixed interest rate       4.80%   4.80%  
Repayment of long-term loan amount | €         € 500,000    
Loan agreement term       4 years 4 years    
Total long-term debt       $ 501,978      
October 13, 2020 [Member] | Namur [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Maturity date       March 2031 March 2031    
Fixed interest rate       4.00%   4.00%  
Repayment of long-term loan amount | €         € 830,000    
Loan agreement term       10 years 10 years    
Total long-term debt       $ 921,411      
On September 16, 2020 [Member] | Bioinformatic Analytics Of Cell Free DNA [Member]              
Repayment of long-term loan amount | €         € 54,879    
Total long-term debt       92,749      
Additional cost of company       155,115      
In 2019 [Member] | Collaborative Arrangement, Co-promotion [Member]              
Collaborative obligations amount due       $ 0      
Research collaboration agreement description       Company entered into a research collaboration agreement with the University of Taiwan for a two-year period to collect a total of 1,200 samples for a cost to the Company of up to $320,000 payable over such period. Company entered into a research collaboration agreement with the University of Taiwan for a two-year period to collect a total of 1,200 samples for a cost to the Company of up to $320,000 payable over such period.    
October 25, 2019 [Member] | TAMU [Member]              
Non-controlling interest       7.50% 7.50%    
Equity interest       12.50% 12.50%    
Additional interest       5.00% 5.00%    
January 10, 2020 [Member]              
Common stock, restricted shares issued in exchange of purchased outstanding shares, value   $ 333,969          
Restricted shares issued | shares   73,263 73,263        
Common stock, restricted shares issued in exchange of purchased outstanding shares, shares | shares   73,263 73,263        
Weighted trading price per share | $ / shares   $ 4.56          
Repayment of debt | €     € 350,000        
Common stock adjusted amount   $ 357,000          
Holdback period       9 months 9 months    
Holdback liabilities       $ 55,404      
Net liabilities   $ 43,152          
August 2021 [Member]              
Compensation expenses       330,837      
Accrued compensation       229,900      
July 1, 2022 [Member]              
Compensation expenses       467,269      
Accrued compensation       116,121      
Operating Lease Right of Use Obligations [Member]              
Short term lease costs       $ 268,870      
Weighted average discount rate       4.49%   4.49%  
Weighted average remaining lease term       30 months 30 months    
Payment of lease liabilities       $ 151,003      
Operating lease expense       $ 151,635      
Namur Innovation and Growth [Member] | In 2018 [Member] | Loan Agreement [Member] | Long-term Debt [Member]              
Maturity date       June 2022 June 2022    
Fixed interest rate       4.00%   4.00%  
Repayment of long-term loan amount | €         € 500,000    
Loan agreement term       4 years 4 years    
Total long-term debt       $ 130,938